Virtual Kidney Check and Follow-up

U

University of Manitoba

Status

Begins enrollment in 2 months

Conditions

Kidney Disease, Chronic

Treatments

Other: population-based screening for chronic kidney disease

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT06223750
HS24845 (H2021:170)

Details and patient eligibility

About

The goal of this clinical trial is to determine the most effective way to complete population-based screening for chronic kidney disease (CKD) in First Nations adults in Manitoba. The main questions it aims to answer are: * To identify chronic kidney disease in First Nations adults in Manitoba * To risk stratify patients as low, moderate and high risk of kidney failure and organize active surveillance by risk category * To initiate treatments to prevent to progression of chronic kidney disease in individuals at risk of kidney failure Participants will be randomized to: 1. Patient contact via mail with a letter and laboratory requisition for serum creatinine and urine Albumin Creatinine Ratio 2. Patient and primary care network contact via mail with a letter but no laboratory requisition The primary outcome is the difference between groups in the proportion of individuals who undergo screening for chronic kidney disease within 6 months.

Enrollment

3,356 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age>= 18 years
  • Resident of Manitoba
  • First Nations
  • Urban, rural or remote location

Exclusion criteria

  • Kidney failure (dialysis or transplant)
  • chronic kidney disease (estimated Glomerular Filtration Rate <60 milliliter/1.73square meter for 3 months)
  • Screening for chronic kidney disease with estimated Glomerular Filtration Rate or Albumin to Creatinine ratio in the last 2 years

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

3,356 participants in 2 patient groups

Patient contact via mail with a letter and laboratory requisition
Other group
Description:
Patient contact via mail with a letter and laboratory requisition for serum creatinine and urine albumin to creatinine ratio
Treatment:
Other: population-based screening for chronic kidney disease
Patient and primary care network contact via mail with a letter but no laboratory requisition
Other group
Treatment:
Other: population-based screening for chronic kidney disease

Trial contacts and locations

0

Loading...

Central trial contact

David Collister, MD, PhD, FRCPC; Maria James, M.Sc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems